Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q693482> ?p ?o }
Showing triples 1 to 44 of
44
with 100 triples per page.
- Q693482 subject Q20747343.
- Q693482 subject Q8297683.
- Q693482 subject Q8965786.
- Q693482 subject Q9052323.
- Q693482 subject Q9062284.
- Q693482 abstract "Roflumilast (trade names Daxas, Daliresp) is a drug that acts as a selective, long-acting inhibitor of the enzyme PDE-4 (Phosphodiesterase-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD).In June 2010, Daxas was approved in the EU for severe COPD associated with chronic bronchitis. In March 2011, Daliresp gained FDA approval in the US for reducing COPD exacerbations.".
- Q693482 atcPrefix "R03".
- Q693482 atcSuffix "DX07".
- Q693482 bioavailability "79.0".
- Q693482 casNumber "162401-32-3".
- Q693482 chEBI "47657".
- Q693482 fdaUniiCode "0P6C6ZOP5U".
- Q693482 iupacName "3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide".
- Q693482 pubchem "449193".
- Q693482 thumbnail Roflumilast_structure.svg?width=300.
- Q693482 wikiPageWikiLink Q14864419.
- Q693482 wikiPageWikiLink Q14890102.
- Q693482 wikiPageWikiLink Q199804.
- Q693482 wikiPageWikiLink Q2043936.
- Q693482 wikiPageWikiLink Q20747343.
- Q693482 wikiPageWikiLink Q30.
- Q693482 wikiPageWikiLink Q458.
- Q693482 wikiPageWikiLink Q581996.
- Q693482 wikiPageWikiLink Q8297683.
- Q693482 wikiPageWikiLink Q8965786.
- Q693482 wikiPageWikiLink Q9052323.
- Q693482 wikiPageWikiLink Q9062284.
- Q693482 wikiPageWikiLink Q9368.
- Q693482 atcPrefix "R03".
- Q693482 atcSuffix "DX07".
- Q693482 bioavailability "79.0".
- Q693482 casNumber "162401".
- Q693482 chebi "47657".
- Q693482 iupacName "3".
- Q693482 pubchem "449193".
- Q693482 unii "0".
- Q693482 type ChemicalSubstance.
- Q693482 type Drug.
- Q693482 type ChemicalObject.
- Q693482 type Thing.
- Q693482 type Q8386.
- Q693482 comment "Roflumilast (trade names Daxas, Daliresp) is a drug that acts as a selective, long-acting inhibitor of the enzyme PDE-4 (Phosphodiesterase-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD).In June 2010, Daxas was approved in the EU for severe COPD associated with chronic bronchitis.".
- Q693482 label "Roflumilast".
- Q693482 depiction Roflumilast_structure.svg.